10x Genomics (TXG) Net Equity Issued and Repurchased (2019 - 2020)
10x Genomics (TXG) posted Net Equity Issued and Repurchased of -$780000.0 for Q4 2020, up 57.95% sequentially from -$1.9 million in Q4 2019, and up 57.95% YoY from -$493822.5 in Q1 2020.
10x Genomics (TXG) Net Equity Issued and Repurchased (2019 - 2020) Analysis & Trends
10x Genomics has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at -$780000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | - |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | - |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | - |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Privia Health | 2.78 Bn | 2.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -780,000.00 |
| Dec 31, 2020 | -780,000.00 |
| Dec 31, 2019 | -1.86 Mn |
| Dec 31, 2019 | -1.86 Mn |